96 barcodes: Expanded PCR-free multiplexing capacity for lower cost per sample – now available in store

Thu 21st May 2020 Latest kit release provides 96 native barcodes for PCR-free sequencing, allowing higher numbers of samples to be run on a single flow cell – including for SARS-CoV-2 whole genome sequencing protocol. The Native Barcoding Expansion (96) kit is available to purchase on the Store now here. Oxford Nanopore provides direct sequencing of... Read more

UK creates COVID-19 genome sequencing alliance for large scale analysis of the virus; Oxford Nanopore sequencing technology supports rapid sequencing capabilities in the network

Mon 23rd March 2020 The UK has formed a genome sequencing alliance, to enable rapid, broad, large-scale sequencing analysis of samples from patients testing positive for COVID-19. The network aims to sequence the virus from every patient sample that has tested positive. The resulting data will help deliver insights into how the virus is transmitted and... Read more

Statement on Jury Verdict in Delaware Trial Against Oxford Nanopore Technologies

MENLO PARK, Calif., March 18, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, announced that the jury verdict in the U.S. District Court for the District of Delaware was not overall favorable for Pacific Biosciences, but mixed in terms of its findings.... Read more

Introducing GridION Mk1

Mon 29th July 2019 GridION is a desktop device that allows simple scaling of MinION and Flongle Flow Cells. Users are able to run up to five flow cells simultaneously, enabling the generation of as much as 150Gb (assuming 30Gb per flow cell) of sequence data if using all five MinION flow cells at the same... Read more

Oxford Nanopore prevails for fourth time in patent hearing

Wed 17th July 2019 Oxford Nanopore has prevailed once again following the decision yesterday by the European Patent Office (EPO) to revoke a second PacBio European Patent, EP3170904. This decision is consistent with that of an earlier EPO decisionrevoking PacBio European Patent EP3045542, as well as rulings from the ITC and US Court of Appeal that the claims of the... Read more

Scale-up: Oxford Nanopore’s new high-tech factory comes online

Mon 8th July 2019 8th July 2019, Oxford, UK: Oxford Nanopore has started high-tech, automated manufacturing processes at its new factory in Oxford, UK. The MinION building is a bespoke, state-of-the-art, high-tech manufacturing facility that brings new, highly automated production processes to the manufacturing of consumable flow cells for Oxford Nanopore’s novel, real-time DNA/RNA sequencing... Read more

GrandOmics collaborates with Oxford Nanopore to deliver dbSV-100k, a project to sequence 100,000 affordable nanopore long-read human genomes

Thu 25th April 2019 Strategic collaboration between two organisations represents largest nanopore sequencing project to date, capitalising on recent developments bringing ultra-high yields with PromethION GrandOmics, a leading sequencing company in China, has announced a populational-scale project, dbSV100k, to understand the impact of structural variation on human disease. The project aims to sequence 20,000 human... Read more

Oxford Nanopore launches Flongle, for rapid, smaller DNA/RNA sequencing tests in any environment

Tue 12th March 2019 Oxford Nanopore has today made Flongle starter packs available to purchase, after initial testing in an early-access programme.  Flongle introduces a new paradigm of smaller, on-demand DNA or RNA sequencing tests, with the potential to transform a range of applications where rapid insights are required at low cost. Oxford Nanopore’s goal is... Read more